文献速递头颈外科咽喉与嗓音

MDADI作为头颈癌患者VFSS分级吞咽障碍的筛查工具

MDADI as a Screening Tool for VFSS-Graded Swallowing Impairment in Head and Neck Cancer Patients.
PubMed 文献 · Laryngoscope · 2026-08-25

本研究回顾性分析208例头颈癌患者的470次MDADI-VFSS配对数据,评估MDADI与VFSS分级吞咽障碍的关联及阈值。结果显示MDADI综合评分与DIGEST和PAS均呈负相关(r=-0.63和-0.50),最佳阈值范围为74-78,约74最能识别DIGEST≥2。四条目简版MDADI与综合评分高度一致(r=0.96),对DIGEST定义障碍有良好区分度(AUC=0.85)。

要点

  • MDADI综合评分与VFSS吞咽障碍分级呈中度负相关,可用于筛查。
  • 综合评分阈值约74可能有助于识别需要吞咽评估的患者。
  • 四条目简版MDADI与完整版高度一致,可减少患者负担。

核心结论

  • MDADI评分与头颈癌患者VFSS分级吞咽障碍相关,综合评分阈值近74或可作为筛查参数。

研究设计与样本

  • 回顾性横断面研究,分析前瞻性吞咽障碍监测项目中208例头颈癌患者的470次MDADI-VFSS观察(PAS)和443次(DIGEST)。

主要发现

  • MDADI综合评分与DIGEST呈中度强负相关(r=-0.63,p<0.001),与PAS呈中度负相关(r=-0.50,p<0.001)。
  • MDADI对两种结局定义均显示良好区分度(AUC 0.78-0.88)。
  • 最佳MDADI阈值范围为74至78,约74最能识别DIGEST≥2。
  • 四条目简版MDADI(F3、E3、E4、P6)与综合评分高度一致(r=0.96),对DIGEST定义障碍的区分度良好(AUC=0.85)。

关键数值与推荐

  • 吞咽障碍采用DIGEST和PAS进行临床相关二分类定义。
  • MDADI综合评分最佳阈值通过Youden J统计量得出,范围为74-78。

临床怎么用

  • MDADI综合评分近74可作为头颈癌患者吞咽障碍的筛查参数,提示需进一步VFSS评估。
  • 四条目简版MDADI可在保持区分度的同时减少患者负担,适合临床筛查使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine clinically useful MD Anderson Dysphagia Inventory (MDADI) thresholds associated with Videofluoroscopic swallow study (VFSS)-graded swallowing impairment in head and neck cancer (HNC) patients and to explore whether a reduced-item MDADI could preserve discrimination while minimizing patient burden. METHODS: This retrospective cross-sectional study analyzed HNC patients from a prospectively maintained dysphagia surveillance program who completed the MDADI within 120 days of VFSS. Associations between MDADI and VFSS metrics were assessed using Spearman and point-biserial correlations. Swallowing impairment was defined using Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) and Penetration-Aspiration Scale (PAS) with clinically relevant dichotomization. Optimal MDADI composite score thresholds were derived using Youden's J statistic, and exploratory item reduction investigated the ability of a concise subset to preserve discrimination of clinically significant impairment. RESULTS: A total of 208 patients contributed 470 MDADI-VFSS observations for PAS and 443 for DIGEST (mean follow-up 3.7 years and MDADI-VFSS interval 56 ± 35.9 days). MDADI composite scores showed moderately strong and moderate inverse correlations with DIGEST (r = -0.63, p < 0.001) and PAS (r = -0.50, p < 0.001), respectively, with good discrimination across both outcome definitions (AUC 0.78-0.88). Optimal MDADI thresholds ranged from 74 to 78 with ~74 best identifying DIGEST ≥ 2. A four-item MDADI short form (F3, E3, E4, and P6) showed strong agreement with Composite score (r = 0.96), with good discrimination of DIGEST-defined impairment (AUC = 0.85). CONCLUSION: MDADI scores correlate with VFSS-graded impairment in HNC patients. A composite threshold near 74 may serve as a clinically useful screening parameter for identifying patients requiring swallowing evaluation.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Brumm ZG, Anyimadu EA, Kohli M, et al. MDADI as a Screening Tool for VFSS-Graded Swallowing Impairment in Head and Neck Cancer Patients. Laryngoscope. 2026. PMID: 42639820. doi:10.1002/lary.70835

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。